A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection

COVID-19 and influenza are both highly contagious respiratory diseases that have been serious threats to global public health. It is necessary to develop a bivalent vaccine to control these two infectious diseases simultaneously. In this study, we generated three attenuated replicating recombinant v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Zhujun, Ouyang, Maggie J., Olukitibi, Titus A., Warner, Bryce, Vendramelli, Robert, Truong, Thang, Meilleur, Courtney, Zhang, Manli, Kung, Sam, Fowke, Keith R., Kobasa, Darwyn, Yao, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517730/
https://www.ncbi.nlm.nih.gov/pubmed/36069551
http://dx.doi.org/10.1128/jvi.01337-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517730/
https://www.ncbi.nlm.nih.gov/pubmed/36069551
http://dx.doi.org/10.1128/jvi.01337-22

Ejemplares similares